UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bladder Pain Syndrome - an Evolution

2nd ed. 2018 edition., 2017

Volltextzugriff (PDF)

Urinary Retention and Post-Void Residual Urine in Men: Separating Truth From Tradition

The Journal of urology, 2008-07, Vol.180 (1), p.47-54

2008

Volltextzugriff (PDF)

Blood-Brain Barrier Permeation and Efflux Exclusion of Anticholinergics Used in the Treatment of Overactive Bladder

Drugs & aging, 2012-04, Vol.29 (4), p.259-273

2012

Volltextzugriff (PDF)

Combination Therapy for Overactive Bladder: Who Approves?

European urology, 2018-10, Vol.74 (4), p.510-511

Staskin, David R.

2018

Volltextzugriff (PDF)

Using Anticholinergics to Treat Overactive Bladder: The Issue of Treatment Tolerability

The American journal of medicine, 2006-03, Vol.119 (3), p.9-15

2006

Volltextzugriff (PDF)

Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence

The Journal of urology, 2019-05, Vol.201 (5), p.967-972

2019

Volltextzugriff (PDF)

Update of AUA Guideline on the Surgical Management of Female Stress Urinary Incontinence

The Journal of urology, 2010-05, Vol.183 (5), p.1906-1914

2010

Volltextzugriff (PDF)

Extended-Release Trospium Chloride Improves Quality of Life in Overactive Bladder

Value in health, 2010-03, Vol.13 (2), p.251-257

2010

Volltextzugriff (PDF)

Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled, Multicenter Study

The Journal of urology, 2009-04, Vol.181 (4), p.1764-1772

2009

Volltextzugriff (PDF)

Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder

Urology (Ridgewood, N.J.), 2010, Vol.75 (1), p.62-68

2010

Volltextzugriff (PDF)

A VALIDATED PATIENT REPORTED MEASURE OF URINARY URGENCY SEVERITY IN OVERACTIVE BLADDER FOR USE IN CLINICAL TRIALS

The Journal of urology, 2005-08, Vol.174 (2), p.604-607

2005

Volltextzugriff (PDF)

Conflict of interest - who benefits?

Neurourology and urodynamics, 2012-11, Vol.31 (8), p.1221-1222

Staskin, David R.

2012

Volltextzugriff (PDF)

Percutaneous Tibial Nerve Stimulation: A Clinically and Cost Effective Addition to the Overactive Bladder Algorithm of Care

Current urology reports, 2012-10, Vol.13 (5), p.327-334

2012

Volltextzugriff (PDF)

Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder

Expert opinion on pharmacotherapy, 2009-12, Vol.10 (18), p.3103-3111

2009

Volltextzugriff (PDF)

Trospium 60 mg Once Daily (QD) for Overactive Bladder Syndrome: Results from a Placebo-Controlled Interventional Study

Urology (Ridgewood, N.J.), 2008-03, Vol.71 (3), p.449-454

2008

Volltextzugriff (PDF)

Overactive bladder in the elderly : A guide to pharmacological management

Drugs & aging, 2005-01, Vol.22 (12), p.1013-1028

STASKIN, David R

2005

Volltextzugriff (PDF)

Efficacy and Safety of Tolterodine Extended Release and Dutasteride in Male Overactive Bladder Patients With Prostates >30 Grams

Urology (Ridgewood, N.J.), 2010-05, Vol.75 (5), p.1144-1148

2010

Volltextzugriff (PDF)

Trospium chloride once‐daily extended release is efficacious and tolerated in elderly subjects (aged ≥75 years) with overactive bladder syndrome

BJU international, 2011-02, Vol.107 (4), p.612-620

2011

Volltextzugriff (PDF)

A call to action: the compelling need to advance the role of urgency

World journal of urology, 2009-12, Vol.27 (6), p.765-766

Staskin, David R.

2009

Volltextzugriff (PDF)

Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects: A 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study

Clinical drug investigation, 2012-10, Vol.32 (10), p.707-714

2012

Volltextzugriff (PDF)

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study

Mayo Clinic proceedings, 2001-04, Vol.76 (4), p.358-363

2001

Volltextzugriff (PDF)

Trospium Chloride: Distinct Among Other Anticholinergic Agents Available for the Treatment of Overactive Bladder

Urologic clinics of North America, 2006-11, Vol.33 (4), p.465-473

Staskin, David R.

2006

Volltextzugriff (PDF)

The Effect of Elective Sham Dose Escalation on the Placebo Response During an Antimuscarinic Trial for Overactive Bladder Symptoms

The Journal of urology, 2012-05, Vol.187 (5), p.1721-1726

2012

Volltextzugriff (PDF)

Short‐ and long‐term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence

BJU international, 2006-06, Vol.97 (6), p.1256-1261

2006

Volltextzugriff (PDF)

Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT Study

Mayo Clinic proceedings, 2001-04, Vol.76 (4), p.358-363

2001

Volltextzugriff (PDF)

1 – 25 von 334

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(273)

Publikationsform

Sprache

Englisch
(334)

Erscheinungsjahr

n.n

Thema

Humans
(88)
Life Sciences & Biomedicine
(84)
Science & Technology
(84)
Urology & Nephrology
(63)
Female
(56)
Male
(41)
Urology & Urogenital Medicine
(41)
Urology
(40)
Biological And Medical Sciences
(39)
Medical Sciences
(39)
Nephrology. Urinary Tract Diseases
(30)
Urinary System Involvement In Other Diseases. Miscellaneous
(28)
Urinary Tract. Prostate Gland
(28)
Middle Aged
(27)
Urinary Incontinence
(27)
Aged
(25)
Treatment Outcome
(21)
Urinary Bladder, Overactive - Drug Therapy
(21)
Adult
(20)
Medicine
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bladder Pain Syndrome - an Evolution

Urinary Retention and Post-Void Residual Urine in Men: Separating Truth From Tradition

Blood-Brain Barrier Permeation and Efflux Exclusion of Anticholinergics Used in the Treatment of Overactive Bladder

Combination Therapy for Overactive Bladder: Who Approves?

Using Anticholinergics to Treat Overactive Bladder: The Issue of Treatment Tolerability

Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence

Update of AUA Guideline on the Surgical Management of Female Stress Urinary Incontinence

Extended-Release Trospium Chloride Improves Quality of Life in Overactive Bladder

Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled, Multicenter Study

Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder

A VALIDATED PATIENT REPORTED MEASURE OF URINARY URGENCY SEVERITY IN OVERACTIVE BLADDER FOR USE IN CLINICAL TRIALS

Conflict of interest - who benefits?

Percutaneous Tibial Nerve Stimulation: A Clinically and Cost Effective Addition to the Overactive Bladder Algorithm of Care

Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder

Trospium 60 mg Once Daily (QD) for Overactive Bladder Syndrome: Results from a Placebo-Controlled Interventional Study

Overactive bladder in the elderly : A guide to pharmacological management

Efficacy and Safety of Tolterodine Extended Release and Dutasteride in Male Overactive Bladder Patients With Prostates >30 Grams

Trospium chloride once‐daily extended release is efficacious and tolerated in elderly subjects (aged ≥75 years) with overactive bladder syndrome

A call to action: the compelling need to advance the role of urgency

Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects: A 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study

Trospium Chloride: Distinct Among Other Anticholinergic Agents Available for the Treatment of Overactive Bladder

The Effect of Elective Sham Dose Escalation on the Placebo Response During an Antimuscarinic Trial for Overactive Bladder Symptoms

Short‐ and long‐term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence

Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT Study

Aktive Filter

Suchergebnisse filtern